Scientific Overview: Internationally Approved HBOT Applications
The following conditions represent medical and therapeutic indications for which hyperbaric oxygen therapy is approved and utilized internationally.
Internationally Recognized Applications of Hyperbaric Oxygen Therapy (HBOT)
Hyperbaric Oxygen Therapy (HBOT) is utilized worldwide for a broad range of medical and therapeutic applications. Internationally, HBOT is recognized for over 100 conditions, supported by varying levels of clinical evidence and decades of global clinical use. These applications are widely referenced by leading hyperbaric and medical organizations, including the Undersea and Hyperbaric Medical Society and the British Hyperbaric Association, among other international authorities.
The following list represents conditions for which HBOT is internationally utilized and supported in clinical practice across multiple countries:
International HBOT Applications
Acute coronary syndrome
Acute ischemic stroke
Attention deficit hyperactivity disorder (ADHD)
Air or gas embolism
Alzheimer’s disease
Severe anemia
Anoxic encephalopathy
Arthritis (rheumatoid and osteoarthritis)
Asthma
Autism spectrum disorder
Avascular necrosis
Bell’s palsy
Brain abscess
Thermal and chemical burns
Cancer treatment support
Carbon monoxide poisoning
Cerebral edema
Cerebral palsy
Chronic fatigue syndrome
Chronic infections
Chronic obstructive pulmonary disease (COPD)
Chronic pain
Clostridial myositis and myonecrosis (gas gangrene)
Compartment syndrome
Complex regional pain syndrome (CRPS)
Concussion
Crohn’s disease
Crush injuries
Cystitis
Decompression sickness
Dementia
Depression
Diabetes mellitus with non-healing wounds
Diabetic ulcers
Diverticulitis
Encephalopathy
Erectile dysfunction
Fibromyalgia
Fracture healing
Frostbite
Gas gangrene
Glaucoma
Migraine and cluster headaches
Sudden sensorineural hearing loss
Heart attack recovery
Heart failure
Hepatitis
HIV/AIDS
Hypertension
Immune system disorders
Inflammatory bowel disease (Crohn’s disease and ulcerative colitis)
Inflammatory conditions
Intracranial abscess
Kidney disease
Leukemia
Lyme disease
Lymphedema
Macular degeneration
Meningitis
Multiple sclerosis
Muscular dystrophy
Near drowning
Near hanging
Necrotizing soft tissue infections
Refractory osteomyelitis
Osteoporosis
Pancreatitis
Parkinson’s disease
Peripheral neuropathy
Peripheral vascular disease
Post-traumatic stress disorder (PTSD)
Pulmonary disease
Radiation cystitis
Radiation-induced soft tissue and bone necrosis
Radiation proctitis
Raynaud’s syndrome
Reflex sympathetic dystrophy
Retinal artery occlusion
Rheumatoid arthritis
Scleroderma
Sepsis
Sickle cell disease
Compromised skin grafts and flaps
Skin ulcers
Spinal cord injuries
Sports injuries
Stroke recovery
Surgery recovery
Systemic lupus erythematosus
Tendonitis
Tinnitus
Transient ischemic attacks (TIAs)
Traumatic brain injury (TBI)
Tuberculosis
Ulcerative colitis
Urinary tract infections
Varicose veins
Vascular dementia
Viral myocarditis
Chronic and non-healing wounds (including diabetic and radiation-related wounds)
Important Note
International utilization of HBOT varies by country, regulatory body, and clinical guidelines. The level of evidence and approval status may differ between regions, and not all indications are universally reimbursable or FDA-cleared in the United States.
For the most comprehensive, up-to-date, and condition-specific guidance, refer to resources published by the Undersea and Hyperbaric Medical Society (UHMS) and the British Hyperbaric Association, as well as other national and international hyperbaric medical organizations.